Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer: a National Cancer Institute of Canada Clinical Trials Group Study
1998

Chemotherapy and Surgery vs Radiotherapy for Lung Cancer

Sample size: 31 publication Evidence: low

Author Information

Author(s): FA Shepherd, MR Johnston, D Payne, R Burkes, J Deslauriers, Y Cormier, LD de Bedoya, J Ottaway, K James, B Zee

Primary Institution: University of Toronto

Hypothesis

Is combined chemotherapy and surgery more effective than radiotherapy alone for stage IIIA non-small-cell lung cancer?

Conclusion

The study found no long-term survival benefit from combined chemotherapy and surgery compared to radiotherapy alone.

Supporting Evidence

  • Response rates to chemotherapy and radiotherapy were 50% and 53.3%, respectively.
  • Median survival times were 16.2 months for radiotherapy alone and 18.7 months for chemotherapy followed by surgery.
  • 62.5% of patients in the chemotherapy-surgery group achieved complete surgical resection.

Takeaway

Doctors wanted to see if giving chemotherapy and surgery together helps lung cancer patients more than just using radiation. They found out it didn't really help in the long run.

Methodology

Patients were randomized to receive either radiotherapy alone or chemotherapy followed by surgery, with various health criteria for inclusion.

Potential Biases

Potential patient selection bias may have influenced the outcomes.

Limitations

The trial closed prematurely and did not reach the intended sample size, limiting the definitiveness of the results.

Participant Demographics

{"gender":{"male":22,"female":9},"age":{"median":56.5,"range":"44-72"}}

Statistical Information

P-Value

Ns

Confidence Interval

{"radiotherapy":"10.7-32.3 months","chemotherapy_surgery":"12.8-32 months"}

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication